Category: AngioDynamics Inc.
AngioDynamics revises its financial results back to the beginning of its 2012 fiscal year, saying it's still assessing its internal controls while getting improved visibility from a new ERP platform.
HeartWare International names Dr. Katrin Leadley to be its new chief medical officer following the retirement of Dr. David Hathaway.
, eLux Medical
, HeartWare International Inc.
, NxStage Medical Inc.
, Revolutions Medical Corp.
, Terumo Corp.
, X2 Biosystems
, AngioDynamics Inc.
AngioDynamics names Concert Medical president Howard Donnelly as chairman, replacing Vincent Bucci, who stepped down last month.
AngioDynamics (NSDQ:ANGO) said today that it tapped Concert Medical president Howard Donnelly to replace outgoing chairman Vincent Bucci.
Bucci, 1st named to the AngioDynamics board in 2007, was named chairman later that year. He stepped down in March.
AngioDynamics reports a profitable fiscal 3rd quarter and nearly doubles Wall Street's earnings forecast, but shares slide anyway.
AngioDynamics (NSDQ:ANGO) put some black ink in the ledger during its fiscal 3rd quarter and handily topped Wall Street's earnings forecast, but investors have remained unmoved, sending ANGO shares down 12% since its April 9 earnings release.
AngioDynamics wins a nearly $75 million judgment against erstwhile partner Biolitec AG over an alleged scheme to evade U.S legal jurisdiction.
New York's AngioDynamics wins updated labeling from FDA regulators, indicating its AngioVac venous drainage system for up to 6 hours at a time.
AngioDynamics (NSDQ:ANGO) tallied a new win for its AngioVac drainage system, with new FDA clearance to market the device for extended use.
New York's AngioDynamics lands FDA clearance for a new BioFlo product and takes charge of distribution partner Medcomp's Celerity tip locater after an FDA loss.